Stomach Cancer in Younger Patients Much More Lethal

Many people under 60 who develop stomach cancer have a genetically and clinically distinct disease, reveals a new study.

High proportion of stomach cancer patients who are below the age of 60 suffer from a particular and genetically unique form of the disease that spreads much more quickly and is resistant to traditional chemotherapy, reports a new study. The findings of the study are published in the journal Surgery.//

While rates of stomach cancer in older patients have been declining for decades, this early onset of cancer is increasing and now makes up more than 30 percent of stomach cancer diagnoses.

Stomach Cancer | Gastric Cancer
Stomach (gastric) cancer develops from the stomach lining. It is the third most common cause for cancer related deaths.

‘Stomach cancer is the 16th most common cancer in the U.S.’
Read More..

"I think this is an alarming trend, as stomach cancer is a devastating disease," said senior author Travis Grotz, a surgical oncologist at Mayo Clinic in the U.S.

The research team studied 75,225 cases using several cancer databases to review stomach cancer statistics from 1973 to 2015.

Today, the average age of someone diagnosed with stomach cancer is 68, but people in their 30s, 40s, and 50s are more at risk than they used to be.

Lifetime Weight Gain of 20kgs Increases Risk of Esophageal, Stomach Cancers
Carrying excess weight can trigger long-term reflux problems and heartburn that can lead to cancer of the esophagus and upper stomach.

"Typically, we see stomach cancer being diagnosed in patients in their 70s, but increasingly we are seeing 30- to 50-year-old patients being diagnosed," Grotz said.

The increased rate of the early onset disease is not from earlier detection or screening, Grotz added.

Potatoes and Cabbage Alleviate Stomach Cancer Risk
Include potatoes and other white vegetables in your diet to reduce the risk of developing stomach cancer, suggest scientists at Zhejiang University in China.

"There is no universal screening for stomach cancer, and the younger patients actually presented with the late-stage disease than the older patients," he said.

In addition to being more deadly, early-onset stomach cancer is also genetically and molecularly distinct, researchers found.

Biosimilar to Trastuzumab Approved for Breast or Metastatic Stomach Cancer
A biological product similar to the earlier USFDA approved trastuzumab has now been cleared for treatment of breast and stomach cancer.

Furthermore, traditional risk factors for developing stomach cancer among older people, such as smoking tobacco, did not appear to correlate with its early onset counterpart.

"Hopefully, studies like this will raise awareness and increase physician suspicion of stomach cancer, particularly in younger patients," Grotz said.

Younger patients who feel full before finishing a meal, or have reflux, abdominal pain, unintentional weight loss, and difficulty eating should see their health care provider, he added.

Source-IANS